Global Cyanocobalamin Injection Market Growth 2025-2031
The global Cyanocobalamin Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Cyanocobalamin is a man-made form of vitamin B12 used to prevent and treat low blood levels of this vitamin. Most people get enough vitamin B12 from their diet. Vitamin B12 is important to maintain the health of your metabolism, blood cells, and nerves.
United States market for Cyanocobalamin Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cyanocobalamin Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cyanocobalamin Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cyanocobalamin Injection players cover Luitpold Pharmaceuticals, Luitpold Pharmaceuticals(Daiichi Sankyo), Endo International, Bristol-Myers Squibb, Sanofi-Aventis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Cyanocobalamin Injection Industry Forecast” looks at past sales and reviews total world Cyanocobalamin Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Cyanocobalamin Injection sales for 2025 through 2031. With Cyanocobalamin Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyanocobalamin Injection industry.
This Insight Report provides a comprehensive analysis of the global Cyanocobalamin Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyanocobalamin Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyanocobalamin Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyanocobalamin Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyanocobalamin Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyanocobalamin Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Cyanocobalamin Injection market?
What factors are driving Cyanocobalamin Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cyanocobalamin Injection market opportunities vary by end market size?
How does Cyanocobalamin Injection break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Cyanocobalamin is a man-made form of vitamin B12 used to prevent and treat low blood levels of this vitamin. Most people get enough vitamin B12 from their diet. Vitamin B12 is important to maintain the health of your metabolism, blood cells, and nerves.
United States market for Cyanocobalamin Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cyanocobalamin Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cyanocobalamin Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cyanocobalamin Injection players cover Luitpold Pharmaceuticals, Luitpold Pharmaceuticals(Daiichi Sankyo), Endo International, Bristol-Myers Squibb, Sanofi-Aventis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Cyanocobalamin Injection Industry Forecast” looks at past sales and reviews total world Cyanocobalamin Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Cyanocobalamin Injection sales for 2025 through 2031. With Cyanocobalamin Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyanocobalamin Injection industry.
This Insight Report provides a comprehensive analysis of the global Cyanocobalamin Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyanocobalamin Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyanocobalamin Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyanocobalamin Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyanocobalamin Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyanocobalamin Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Vitamins
- Supplements
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Luitpold Pharmaceuticals
- Luitpold Pharmaceuticals(Daiichi Sankyo)
- Endo International
- Bristol-Myers Squibb
- Sanofi-Aventis
- Jamieson
- Teva(Actavis)
- Merck
- Mylan
- Bayer HealthCare
- Pfizer
- ANGELINI
- Biological E
- CCEPCD
- Huaxin Pharmaceutical
What is the 10-year outlook for the global Cyanocobalamin Injection market?
What factors are driving Cyanocobalamin Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cyanocobalamin Injection market opportunities vary by end market size?
How does Cyanocobalamin Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Angina Pectoris Drugs Market Size (2020-2031)
2.1.2 Angina Pectoris Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Angina Pectoris Drugs by Country/Region (2020, 2024 & 2031)
2.2 Angina Pectoris Drugs Segment by Type
2.2.1 Beta Blockers
2.2.2 Calcium Antagonists
2.2.3 Anticoagulants
2.2.4 Anti-Platelets
2.2.5 Others
2.3 Angina Pectoris Drugs Market Size by Type
2.3.1 Angina Pectoris Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Angina Pectoris Drugs Market Size Market Share by Type (2020-2025)
2.4 Angina Pectoris Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 ASCs
2.5 Angina Pectoris Drugs Market Size by Application
2.5.1 Angina Pectoris Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Angina Pectoris Drugs Market Size Market Share by Application (2020-2025)
3 ANGINA PECTORIS DRUGS MARKET SIZE BY PLAYER
3.1 Angina Pectoris Drugs Market Size Market Share by Player
3.1.1 Global Angina Pectoris Drugs Revenue by Player (2020-2025)
3.1.2 Global Angina Pectoris Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Angina Pectoris Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANGINA PECTORIS DRUGS BY REGION
4.1 Angina Pectoris Drugs Market Size by Region (2020-2025)
4.2 Global Angina Pectoris Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Angina Pectoris Drugs Market Size Growth (2020-2025)
4.4 APAC Angina Pectoris Drugs Market Size Growth (2020-2025)
4.5 Europe Angina Pectoris Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Angina Pectoris Drugs Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Angina Pectoris Drugs Market Size by Country (2020-2025)
5.2 Americas Angina Pectoris Drugs Market Size by Type (2020-2025)
5.3 Americas Angina Pectoris Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Angina Pectoris Drugs Market Size by Region (2020-2025)
6.2 APAC Angina Pectoris Drugs Market Size by Type (2020-2025)
6.3 APAC Angina Pectoris Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Angina Pectoris Drugs Market Size by Country (2020-2025)
7.2 Europe Angina Pectoris Drugs Market Size by Type (2020-2025)
7.3 Europe Angina Pectoris Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Angina Pectoris Drugs by Region (2020-2025)
8.2 Middle East & Africa Angina Pectoris Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Angina Pectoris Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANGINA PECTORIS DRUGS MARKET FORECAST
10.1 Global Angina Pectoris Drugs Forecast by Region (2026-2031)
10.1.1 Global Angina Pectoris Drugs Forecast by Region (2026-2031)
10.1.2 Americas Angina Pectoris Drugs Forecast
10.1.3 APAC Angina Pectoris Drugs Forecast
10.1.4 Europe Angina Pectoris Drugs Forecast
10.1.5 Middle East & Africa Angina Pectoris Drugs Forecast
10.2 Americas Angina Pectoris Drugs Forecast by Country (2026-2031)
10.2.1 United States Market Angina Pectoris Drugs Forecast
10.2.2 Canada Market Angina Pectoris Drugs Forecast
10.2.3 Mexico Market Angina Pectoris Drugs Forecast
10.2.4 Brazil Market Angina Pectoris Drugs Forecast
10.3 APAC Angina Pectoris Drugs Forecast by Region (2026-2031)
10.3.1 China Angina Pectoris Drugs Market Forecast
10.3.2 Japan Market Angina Pectoris Drugs Forecast
10.3.3 Korea Market Angina Pectoris Drugs Forecast
10.3.4 Southeast Asia Market Angina Pectoris Drugs Forecast
10.3.5 India Market Angina Pectoris Drugs Forecast
10.3.6 Australia Market Angina Pectoris Drugs Forecast
10.4 Europe Angina Pectoris Drugs Forecast by Country (2026-2031)
10.4.1 Germany Market Angina Pectoris Drugs Forecast
10.4.2 France Market Angina Pectoris Drugs Forecast
10.4.3 UK Market Angina Pectoris Drugs Forecast
10.4.4 Italy Market Angina Pectoris Drugs Forecast
10.4.5 Russia Market Angina Pectoris Drugs Forecast
10.5 Middle East & Africa Angina Pectoris Drugs Forecast by Region (2026-2031)
10.5.1 Egypt Market Angina Pectoris Drugs Forecast
10.5.2 South Africa Market Angina Pectoris Drugs Forecast
10.5.3 Israel Market Angina Pectoris Drugs Forecast
10.5.4 Turkey Market Angina Pectoris Drugs Forecast
10.6 Global Angina Pectoris Drugs Forecast by Type (2026-2031)
10.7 Global Angina Pectoris Drugs Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Angina Pectoris Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Angina Pectoris Drugs Product Offered
11.1.3 Pfizer Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Angina Pectoris Drugs Product Offered
11.2.3 Bayer Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Angina Pectoris Drugs Product Offered
11.3.3 AstraZeneca Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Gilead
11.4.1 Gilead Company Information
11.4.2 Gilead Angina Pectoris Drugs Product Offered
11.4.3 Gilead Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Gilead Main Business Overview
11.4.5 Gilead Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Angina Pectoris Drugs Product Offered
11.5.3 Novartis Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Angina Pectoris Drugs Product Offered
11.6.3 GlaxoSmithKline Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Angina Pectoris Drugs Product Offered
11.7.3 Merck Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Angina Pectoris Drugs Product Offered
11.8.3 Mylan Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Mylan Main Business Overview
11.8.5 Mylan Latest Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Information
11.9.2 Teva Pharmaceutical Angina Pectoris Drugs Product Offered
11.9.3 Teva Pharmaceutical Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Teva Pharmaceutical Main Business Overview
11.9.5 Teva Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Angina Pectoris Drugs Market Size (2020-2031)
2.1.2 Angina Pectoris Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Angina Pectoris Drugs by Country/Region (2020, 2024 & 2031)
2.2 Angina Pectoris Drugs Segment by Type
2.2.1 Beta Blockers
2.2.2 Calcium Antagonists
2.2.3 Anticoagulants
2.2.4 Anti-Platelets
2.2.5 Others
2.3 Angina Pectoris Drugs Market Size by Type
2.3.1 Angina Pectoris Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Angina Pectoris Drugs Market Size Market Share by Type (2020-2025)
2.4 Angina Pectoris Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 ASCs
2.5 Angina Pectoris Drugs Market Size by Application
2.5.1 Angina Pectoris Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Angina Pectoris Drugs Market Size Market Share by Application (2020-2025)
3 ANGINA PECTORIS DRUGS MARKET SIZE BY PLAYER
3.1 Angina Pectoris Drugs Market Size Market Share by Player
3.1.1 Global Angina Pectoris Drugs Revenue by Player (2020-2025)
3.1.2 Global Angina Pectoris Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Angina Pectoris Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANGINA PECTORIS DRUGS BY REGION
4.1 Angina Pectoris Drugs Market Size by Region (2020-2025)
4.2 Global Angina Pectoris Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Angina Pectoris Drugs Market Size Growth (2020-2025)
4.4 APAC Angina Pectoris Drugs Market Size Growth (2020-2025)
4.5 Europe Angina Pectoris Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Angina Pectoris Drugs Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Angina Pectoris Drugs Market Size by Country (2020-2025)
5.2 Americas Angina Pectoris Drugs Market Size by Type (2020-2025)
5.3 Americas Angina Pectoris Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Angina Pectoris Drugs Market Size by Region (2020-2025)
6.2 APAC Angina Pectoris Drugs Market Size by Type (2020-2025)
6.3 APAC Angina Pectoris Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Angina Pectoris Drugs Market Size by Country (2020-2025)
7.2 Europe Angina Pectoris Drugs Market Size by Type (2020-2025)
7.3 Europe Angina Pectoris Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Angina Pectoris Drugs by Region (2020-2025)
8.2 Middle East & Africa Angina Pectoris Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Angina Pectoris Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANGINA PECTORIS DRUGS MARKET FORECAST
10.1 Global Angina Pectoris Drugs Forecast by Region (2026-2031)
10.1.1 Global Angina Pectoris Drugs Forecast by Region (2026-2031)
10.1.2 Americas Angina Pectoris Drugs Forecast
10.1.3 APAC Angina Pectoris Drugs Forecast
10.1.4 Europe Angina Pectoris Drugs Forecast
10.1.5 Middle East & Africa Angina Pectoris Drugs Forecast
10.2 Americas Angina Pectoris Drugs Forecast by Country (2026-2031)
10.2.1 United States Market Angina Pectoris Drugs Forecast
10.2.2 Canada Market Angina Pectoris Drugs Forecast
10.2.3 Mexico Market Angina Pectoris Drugs Forecast
10.2.4 Brazil Market Angina Pectoris Drugs Forecast
10.3 APAC Angina Pectoris Drugs Forecast by Region (2026-2031)
10.3.1 China Angina Pectoris Drugs Market Forecast
10.3.2 Japan Market Angina Pectoris Drugs Forecast
10.3.3 Korea Market Angina Pectoris Drugs Forecast
10.3.4 Southeast Asia Market Angina Pectoris Drugs Forecast
10.3.5 India Market Angina Pectoris Drugs Forecast
10.3.6 Australia Market Angina Pectoris Drugs Forecast
10.4 Europe Angina Pectoris Drugs Forecast by Country (2026-2031)
10.4.1 Germany Market Angina Pectoris Drugs Forecast
10.4.2 France Market Angina Pectoris Drugs Forecast
10.4.3 UK Market Angina Pectoris Drugs Forecast
10.4.4 Italy Market Angina Pectoris Drugs Forecast
10.4.5 Russia Market Angina Pectoris Drugs Forecast
10.5 Middle East & Africa Angina Pectoris Drugs Forecast by Region (2026-2031)
10.5.1 Egypt Market Angina Pectoris Drugs Forecast
10.5.2 South Africa Market Angina Pectoris Drugs Forecast
10.5.3 Israel Market Angina Pectoris Drugs Forecast
10.5.4 Turkey Market Angina Pectoris Drugs Forecast
10.6 Global Angina Pectoris Drugs Forecast by Type (2026-2031)
10.7 Global Angina Pectoris Drugs Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Angina Pectoris Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Angina Pectoris Drugs Product Offered
11.1.3 Pfizer Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Angina Pectoris Drugs Product Offered
11.2.3 Bayer Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Angina Pectoris Drugs Product Offered
11.3.3 AstraZeneca Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Gilead
11.4.1 Gilead Company Information
11.4.2 Gilead Angina Pectoris Drugs Product Offered
11.4.3 Gilead Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Gilead Main Business Overview
11.4.5 Gilead Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Angina Pectoris Drugs Product Offered
11.5.3 Novartis Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Angina Pectoris Drugs Product Offered
11.6.3 GlaxoSmithKline Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Angina Pectoris Drugs Product Offered
11.7.3 Merck Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Angina Pectoris Drugs Product Offered
11.8.3 Mylan Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Mylan Main Business Overview
11.8.5 Mylan Latest Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Information
11.9.2 Teva Pharmaceutical Angina Pectoris Drugs Product Offered
11.9.3 Teva Pharmaceutical Angina Pectoris Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Teva Pharmaceutical Main Business Overview
11.9.5 Teva Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cyanocobalamin Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Cyanocobalamin Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Vitamins
Table 4. Major Players of Supplements
Table 5. Global Cyanocobalamin Injection Sales by Type (2020-2025) & (K Doses)
Table 6. Global Cyanocobalamin Injection Sales Market Share by Type (2020-2025)
Table 7. Global Cyanocobalamin Injection Revenue by Type (2020-2025) & ($ million)
Table 8. Global Cyanocobalamin Injection Revenue Market Share by Type (2020-2025)
Table 9. Global Cyanocobalamin Injection Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Cyanocobalamin Injection Sale by Application (2020-2025) & (K Doses)
Table 11. Global Cyanocobalamin Injection Sale Market Share by Application (2020-2025)
Table 12. Global Cyanocobalamin Injection Revenue by Application (2020-2025) & ($ million)
Table 13. Global Cyanocobalamin Injection Revenue Market Share by Application (2020-2025)
Table 14. Global Cyanocobalamin Injection Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Cyanocobalamin Injection Sales by Company (2020-2025) & (K Doses)
Table 16. Global Cyanocobalamin Injection Sales Market Share by Company (2020-2025)
Table 17. Global Cyanocobalamin Injection Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Cyanocobalamin Injection Revenue Market Share by Company (2020-2025)
Table 19. Global Cyanocobalamin Injection Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Cyanocobalamin Injection Producing Area Distribution and Sales Area
Table 21. Players Cyanocobalamin Injection Products Offered
Table 22. Cyanocobalamin Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Cyanocobalamin Injection Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Cyanocobalamin Injection Sales Market Share Geographic Region (2020-2025)
Table 27. Global Cyanocobalamin Injection Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Cyanocobalamin Injection Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Cyanocobalamin Injection Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Cyanocobalamin Injection Sales Market Share by Country/Region (2020-2025)
Table 31. Global Cyanocobalamin Injection Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Cyanocobalamin Injection Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Cyanocobalamin Injection Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Cyanocobalamin Injection Sales Market Share by Country (2020-2025)
Table 35. Americas Cyanocobalamin Injection Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Cyanocobalamin Injection Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Cyanocobalamin Injection Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Cyanocobalamin Injection Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Cyanocobalamin Injection Sales Market Share by Region (2020-2025)
Table 40. APAC Cyanocobalamin Injection Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Cyanocobalamin Injection Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Cyanocobalamin Injection Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Cyanocobalamin Injection Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Cyanocobalamin Injection Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Cyanocobalamin Injection Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Cyanocobalamin Injection Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Cyanocobalamin Injection Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Cyanocobalamin Injection Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Cyanocobalamin Injection Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Cyanocobalamin Injection Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Cyanocobalamin Injection
Table 52. Key Market Challenges & Risks of Cyanocobalamin Injection
Table 53. Key Industry Trends of Cyanocobalamin Injection
Table 54. Cyanocobalamin Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Cyanocobalamin Injection Distributors List
Table 57. Cyanocobalamin Injection Customer List
Table 58. Global Cyanocobalamin Injection Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Cyanocobalamin Injection Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Cyanocobalamin Injection Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Cyanocobalamin Injection Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Cyanocobalamin Injection Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Cyanocobalamin Injection Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Cyanocobalamin Injection Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Cyanocobalamin Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Cyanocobalamin Injection Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Cyanocobalamin Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Cyanocobalamin Injection Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Cyanocobalamin Injection Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Cyanocobalamin Injection Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Cyanocobalamin Injection Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Luitpold Pharmaceuticals Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Luitpold Pharmaceuticals Cyanocobalamin Injection Product Portfolios and Specifications
Table 74. Luitpold Pharmaceuticals Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Luitpold Pharmaceuticals Main Business
Table 76. Luitpold Pharmaceuticals Latest Developments
Table 77. Luitpold Pharmaceuticals(Daiichi Sankyo) Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Product Portfolios and Specifications
Table 79. Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Luitpold Pharmaceuticals(Daiichi Sankyo) Main Business
Table 81. Luitpold Pharmaceuticals(Daiichi Sankyo) Latest Developments
Table 82. Endo International Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Endo International Cyanocobalamin Injection Product Portfolios and Specifications
Table 84. Endo International Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Endo International Main Business
Table 86. Endo International Latest Developments
Table 87. Bristol-Myers Squibb Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Bristol-Myers Squibb Cyanocobalamin Injection Product Portfolios and Specifications
Table 89. Bristol-Myers Squibb Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Bristol-Myers Squibb Main Business
Table 91. Bristol-Myers Squibb Latest Developments
Table 92. Sanofi-Aventis Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi-Aventis Cyanocobalamin Injection Product Portfolios and Specifications
Table 94. Sanofi-Aventis Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Sanofi-Aventis Main Business
Table 96. Sanofi-Aventis Latest Developments
Table 97. Jamieson Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Jamieson Cyanocobalamin Injection Product Portfolios and Specifications
Table 99. Jamieson Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Jamieson Main Business
Table 101. Jamieson Latest Developments
Table 102. Teva(Actavis) Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva(Actavis) Cyanocobalamin Injection Product Portfolios and Specifications
Table 104. Teva(Actavis) Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. Teva(Actavis) Main Business
Table 106. Teva(Actavis) Latest Developments
Table 107. Merck Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck Cyanocobalamin Injection Product Portfolios and Specifications
Table 109. Merck Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. Merck Main Business
Table 111. Merck Latest Developments
Table 112. Mylan Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan Cyanocobalamin Injection Product Portfolios and Specifications
Table 114. Mylan Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. Mylan Main Business
Table 116. Mylan Latest Developments
Table 117. Bayer HealthCare Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Bayer HealthCare Cyanocobalamin Injection Product Portfolios and Specifications
Table 119. Bayer HealthCare Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 120. Bayer HealthCare Main Business
Table 121. Bayer HealthCare Latest Developments
Table 122. Pfizer Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Pfizer Cyanocobalamin Injection Product Portfolios and Specifications
Table 124. Pfizer Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 125. Pfizer Main Business
Table 126. Pfizer Latest Developments
Table 127. ANGELINI Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. ANGELINI Cyanocobalamin Injection Product Portfolios and Specifications
Table 129. ANGELINI Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 130. ANGELINI Main Business
Table 131. ANGELINI Latest Developments
Table 132. Biological E Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Biological E Cyanocobalamin Injection Product Portfolios and Specifications
Table 134. Biological E Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 135. Biological E Main Business
Table 136. Biological E Latest Developments
Table 137. CCEPCD Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. CCEPCD Cyanocobalamin Injection Product Portfolios and Specifications
Table 139. CCEPCD Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 140. CCEPCD Main Business
Table 141. CCEPCD Latest Developments
Table 142. Huaxin Pharmaceutical Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 143. Huaxin Pharmaceutical Cyanocobalamin Injection Product Portfolios and Specifications
Table 144. Huaxin Pharmaceutical Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 145. Huaxin Pharmaceutical Main Business
Table 146. Huaxin Pharmaceutical Latest Developments
Table 1. Cyanocobalamin Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Cyanocobalamin Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Vitamins
Table 4. Major Players of Supplements
Table 5. Global Cyanocobalamin Injection Sales by Type (2020-2025) & (K Doses)
Table 6. Global Cyanocobalamin Injection Sales Market Share by Type (2020-2025)
Table 7. Global Cyanocobalamin Injection Revenue by Type (2020-2025) & ($ million)
Table 8. Global Cyanocobalamin Injection Revenue Market Share by Type (2020-2025)
Table 9. Global Cyanocobalamin Injection Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Cyanocobalamin Injection Sale by Application (2020-2025) & (K Doses)
Table 11. Global Cyanocobalamin Injection Sale Market Share by Application (2020-2025)
Table 12. Global Cyanocobalamin Injection Revenue by Application (2020-2025) & ($ million)
Table 13. Global Cyanocobalamin Injection Revenue Market Share by Application (2020-2025)
Table 14. Global Cyanocobalamin Injection Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Cyanocobalamin Injection Sales by Company (2020-2025) & (K Doses)
Table 16. Global Cyanocobalamin Injection Sales Market Share by Company (2020-2025)
Table 17. Global Cyanocobalamin Injection Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Cyanocobalamin Injection Revenue Market Share by Company (2020-2025)
Table 19. Global Cyanocobalamin Injection Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Cyanocobalamin Injection Producing Area Distribution and Sales Area
Table 21. Players Cyanocobalamin Injection Products Offered
Table 22. Cyanocobalamin Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Cyanocobalamin Injection Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Cyanocobalamin Injection Sales Market Share Geographic Region (2020-2025)
Table 27. Global Cyanocobalamin Injection Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Cyanocobalamin Injection Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Cyanocobalamin Injection Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Cyanocobalamin Injection Sales Market Share by Country/Region (2020-2025)
Table 31. Global Cyanocobalamin Injection Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Cyanocobalamin Injection Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Cyanocobalamin Injection Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Cyanocobalamin Injection Sales Market Share by Country (2020-2025)
Table 35. Americas Cyanocobalamin Injection Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Cyanocobalamin Injection Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Cyanocobalamin Injection Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Cyanocobalamin Injection Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Cyanocobalamin Injection Sales Market Share by Region (2020-2025)
Table 40. APAC Cyanocobalamin Injection Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Cyanocobalamin Injection Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Cyanocobalamin Injection Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Cyanocobalamin Injection Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Cyanocobalamin Injection Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Cyanocobalamin Injection Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Cyanocobalamin Injection Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Cyanocobalamin Injection Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Cyanocobalamin Injection Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Cyanocobalamin Injection Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Cyanocobalamin Injection Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Cyanocobalamin Injection
Table 52. Key Market Challenges & Risks of Cyanocobalamin Injection
Table 53. Key Industry Trends of Cyanocobalamin Injection
Table 54. Cyanocobalamin Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Cyanocobalamin Injection Distributors List
Table 57. Cyanocobalamin Injection Customer List
Table 58. Global Cyanocobalamin Injection Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Cyanocobalamin Injection Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Cyanocobalamin Injection Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Cyanocobalamin Injection Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Cyanocobalamin Injection Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Cyanocobalamin Injection Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Cyanocobalamin Injection Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Cyanocobalamin Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Cyanocobalamin Injection Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Cyanocobalamin Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Cyanocobalamin Injection Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Cyanocobalamin Injection Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Cyanocobalamin Injection Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Cyanocobalamin Injection Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Luitpold Pharmaceuticals Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Luitpold Pharmaceuticals Cyanocobalamin Injection Product Portfolios and Specifications
Table 74. Luitpold Pharmaceuticals Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Luitpold Pharmaceuticals Main Business
Table 76. Luitpold Pharmaceuticals Latest Developments
Table 77. Luitpold Pharmaceuticals(Daiichi Sankyo) Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Product Portfolios and Specifications
Table 79. Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Luitpold Pharmaceuticals(Daiichi Sankyo) Main Business
Table 81. Luitpold Pharmaceuticals(Daiichi Sankyo) Latest Developments
Table 82. Endo International Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Endo International Cyanocobalamin Injection Product Portfolios and Specifications
Table 84. Endo International Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Endo International Main Business
Table 86. Endo International Latest Developments
Table 87. Bristol-Myers Squibb Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Bristol-Myers Squibb Cyanocobalamin Injection Product Portfolios and Specifications
Table 89. Bristol-Myers Squibb Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Bristol-Myers Squibb Main Business
Table 91. Bristol-Myers Squibb Latest Developments
Table 92. Sanofi-Aventis Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi-Aventis Cyanocobalamin Injection Product Portfolios and Specifications
Table 94. Sanofi-Aventis Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Sanofi-Aventis Main Business
Table 96. Sanofi-Aventis Latest Developments
Table 97. Jamieson Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Jamieson Cyanocobalamin Injection Product Portfolios and Specifications
Table 99. Jamieson Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Jamieson Main Business
Table 101. Jamieson Latest Developments
Table 102. Teva(Actavis) Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva(Actavis) Cyanocobalamin Injection Product Portfolios and Specifications
Table 104. Teva(Actavis) Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. Teva(Actavis) Main Business
Table 106. Teva(Actavis) Latest Developments
Table 107. Merck Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck Cyanocobalamin Injection Product Portfolios and Specifications
Table 109. Merck Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. Merck Main Business
Table 111. Merck Latest Developments
Table 112. Mylan Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan Cyanocobalamin Injection Product Portfolios and Specifications
Table 114. Mylan Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. Mylan Main Business
Table 116. Mylan Latest Developments
Table 117. Bayer HealthCare Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Bayer HealthCare Cyanocobalamin Injection Product Portfolios and Specifications
Table 119. Bayer HealthCare Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 120. Bayer HealthCare Main Business
Table 121. Bayer HealthCare Latest Developments
Table 122. Pfizer Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Pfizer Cyanocobalamin Injection Product Portfolios and Specifications
Table 124. Pfizer Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 125. Pfizer Main Business
Table 126. Pfizer Latest Developments
Table 127. ANGELINI Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. ANGELINI Cyanocobalamin Injection Product Portfolios and Specifications
Table 129. ANGELINI Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 130. ANGELINI Main Business
Table 131. ANGELINI Latest Developments
Table 132. Biological E Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Biological E Cyanocobalamin Injection Product Portfolios and Specifications
Table 134. Biological E Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 135. Biological E Main Business
Table 136. Biological E Latest Developments
Table 137. CCEPCD Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. CCEPCD Cyanocobalamin Injection Product Portfolios and Specifications
Table 139. CCEPCD Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 140. CCEPCD Main Business
Table 141. CCEPCD Latest Developments
Table 142. Huaxin Pharmaceutical Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 143. Huaxin Pharmaceutical Cyanocobalamin Injection Product Portfolios and Specifications
Table 144. Huaxin Pharmaceutical Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 145. Huaxin Pharmaceutical Main Business
Table 146. Huaxin Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Cyanocobalamin Injection
Figure 2. Cyanocobalamin Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyanocobalamin Injection Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Cyanocobalamin Injection Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Cyanocobalamin Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Cyanocobalamin Injection Sales Market Share by Country/Region (2024)
Figure 10. Cyanocobalamin Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Vitamins
Figure 12. Product Picture of Supplements
Figure 13. Global Cyanocobalamin Injection Sales Market Share by Type in 2025
Figure 14. Global Cyanocobalamin Injection Revenue Market Share by Type (2020-2025)
Figure 15. Cyanocobalamin Injection Consumed in Hospitals
Figure 16. Global Cyanocobalamin Injection Market: Hospitals (2020-2025) & (K Doses)
Figure 17. Cyanocobalamin Injection Consumed in Clinics
Figure 18. Global Cyanocobalamin Injection Market: Clinics (2020-2025) & (K Doses)
Figure 19. Cyanocobalamin Injection Consumed in Others
Figure 20. Global Cyanocobalamin Injection Market: Others (2020-2025) & (K Doses)
Figure 21. Global Cyanocobalamin Injection Sale Market Share by Application (2024)
Figure 22. Global Cyanocobalamin Injection Revenue Market Share by Application in 2025
Figure 23. Cyanocobalamin Injection Sales by Company in 2025 (K Doses)
Figure 24. Global Cyanocobalamin Injection Sales Market Share by Company in 2025
Figure 25. Cyanocobalamin Injection Revenue by Company in 2025 ($ millions)
Figure 26. Global Cyanocobalamin Injection Revenue Market Share by Company in 2025
Figure 27. Global Cyanocobalamin Injection Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Cyanocobalamin Injection Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Cyanocobalamin Injection Sales 2020-2025 (K Doses)
Figure 30. Americas Cyanocobalamin Injection Revenue 2020-2025 ($ millions)
Figure 31. APAC Cyanocobalamin Injection Sales 2020-2025 (K Doses)
Figure 32. APAC Cyanocobalamin Injection Revenue 2020-2025 ($ millions)
Figure 33. Europe Cyanocobalamin Injection Sales 2020-2025 (K Doses)
Figure 34. Europe Cyanocobalamin Injection Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Cyanocobalamin Injection Sales 2020-2025 (K Doses)
Figure 36. Middle East & Africa Cyanocobalamin Injection Revenue 2020-2025 ($ millions)
Figure 37. Americas Cyanocobalamin Injection Sales Market Share by Country in 2025
Figure 38. Americas Cyanocobalamin Injection Revenue Market Share by Country (2020-2025)
Figure 39. Americas Cyanocobalamin Injection Sales Market Share by Type (2020-2025)
Figure 40. Americas Cyanocobalamin Injection Sales Market Share by Application (2020-2025)
Figure 41. United States Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Cyanocobalamin Injection Sales Market Share by Region in 2025
Figure 46. APAC Cyanocobalamin Injection Revenue Market Share by Region (2020-2025)
Figure 47. APAC Cyanocobalamin Injection Sales Market Share by Type (2020-2025)
Figure 48. APAC Cyanocobalamin Injection Sales Market Share by Application (2020-2025)
Figure 49. China Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 53. India Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Cyanocobalamin Injection Sales Market Share by Country in 2025
Figure 57. Europe Cyanocobalamin Injection Revenue Market Share by Country (2020-2025)
Figure 58. Europe Cyanocobalamin Injection Sales Market Share by Type (2020-2025)
Figure 59. Europe Cyanocobalamin Injection Sales Market Share by Application (2020-2025)
Figure 60. Germany Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 61. France Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Application (2020-2025)
Figure 68. Egypt Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Cyanocobalamin Injection in 2025
Figure 74. Manufacturing Process Analysis of Cyanocobalamin Injection
Figure 75. Industry Chain Structure of Cyanocobalamin Injection
Figure 76. Channels of Distribution
Figure 77. Global Cyanocobalamin Injection Sales Market Forecast by Region (2026-2031)
Figure 78. Global Cyanocobalamin Injection Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Cyanocobalamin Injection Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Cyanocobalamin Injection Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Cyanocobalamin Injection Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Cyanocobalamin Injection Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Cyanocobalamin Injection
Figure 2. Cyanocobalamin Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyanocobalamin Injection Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Cyanocobalamin Injection Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Cyanocobalamin Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Cyanocobalamin Injection Sales Market Share by Country/Region (2024)
Figure 10. Cyanocobalamin Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Vitamins
Figure 12. Product Picture of Supplements
Figure 13. Global Cyanocobalamin Injection Sales Market Share by Type in 2025
Figure 14. Global Cyanocobalamin Injection Revenue Market Share by Type (2020-2025)
Figure 15. Cyanocobalamin Injection Consumed in Hospitals
Figure 16. Global Cyanocobalamin Injection Market: Hospitals (2020-2025) & (K Doses)
Figure 17. Cyanocobalamin Injection Consumed in Clinics
Figure 18. Global Cyanocobalamin Injection Market: Clinics (2020-2025) & (K Doses)
Figure 19. Cyanocobalamin Injection Consumed in Others
Figure 20. Global Cyanocobalamin Injection Market: Others (2020-2025) & (K Doses)
Figure 21. Global Cyanocobalamin Injection Sale Market Share by Application (2024)
Figure 22. Global Cyanocobalamin Injection Revenue Market Share by Application in 2025
Figure 23. Cyanocobalamin Injection Sales by Company in 2025 (K Doses)
Figure 24. Global Cyanocobalamin Injection Sales Market Share by Company in 2025
Figure 25. Cyanocobalamin Injection Revenue by Company in 2025 ($ millions)
Figure 26. Global Cyanocobalamin Injection Revenue Market Share by Company in 2025
Figure 27. Global Cyanocobalamin Injection Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Cyanocobalamin Injection Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Cyanocobalamin Injection Sales 2020-2025 (K Doses)
Figure 30. Americas Cyanocobalamin Injection Revenue 2020-2025 ($ millions)
Figure 31. APAC Cyanocobalamin Injection Sales 2020-2025 (K Doses)
Figure 32. APAC Cyanocobalamin Injection Revenue 2020-2025 ($ millions)
Figure 33. Europe Cyanocobalamin Injection Sales 2020-2025 (K Doses)
Figure 34. Europe Cyanocobalamin Injection Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Cyanocobalamin Injection Sales 2020-2025 (K Doses)
Figure 36. Middle East & Africa Cyanocobalamin Injection Revenue 2020-2025 ($ millions)
Figure 37. Americas Cyanocobalamin Injection Sales Market Share by Country in 2025
Figure 38. Americas Cyanocobalamin Injection Revenue Market Share by Country (2020-2025)
Figure 39. Americas Cyanocobalamin Injection Sales Market Share by Type (2020-2025)
Figure 40. Americas Cyanocobalamin Injection Sales Market Share by Application (2020-2025)
Figure 41. United States Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Cyanocobalamin Injection Sales Market Share by Region in 2025
Figure 46. APAC Cyanocobalamin Injection Revenue Market Share by Region (2020-2025)
Figure 47. APAC Cyanocobalamin Injection Sales Market Share by Type (2020-2025)
Figure 48. APAC Cyanocobalamin Injection Sales Market Share by Application (2020-2025)
Figure 49. China Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 53. India Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Cyanocobalamin Injection Sales Market Share by Country in 2025
Figure 57. Europe Cyanocobalamin Injection Revenue Market Share by Country (2020-2025)
Figure 58. Europe Cyanocobalamin Injection Sales Market Share by Type (2020-2025)
Figure 59. Europe Cyanocobalamin Injection Sales Market Share by Application (2020-2025)
Figure 60. Germany Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 61. France Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Application (2020-2025)
Figure 68. Egypt Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Cyanocobalamin Injection Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Cyanocobalamin Injection in 2025
Figure 74. Manufacturing Process Analysis of Cyanocobalamin Injection
Figure 75. Industry Chain Structure of Cyanocobalamin Injection
Figure 76. Channels of Distribution
Figure 77. Global Cyanocobalamin Injection Sales Market Forecast by Region (2026-2031)
Figure 78. Global Cyanocobalamin Injection Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Cyanocobalamin Injection Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Cyanocobalamin Injection Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Cyanocobalamin Injection Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Cyanocobalamin Injection Revenue Market Share Forecast by Application (2026-2031)
